$ACAD
Acadia Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
$20.59
▼-0.82%-$0.170
Acadia Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is ACAD down today? It is at $20.59 (-0.82%), and our scanner flagged it 81 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACAD spikes, and full due diligence on ACAD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACAD 81 times in the last 30 days. Create a free account to track $ACAD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ACAD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACAD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystExecutive / Board Change, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 31, 2026 · yesterdaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Schneyer Mark C. Officer | Sold (automatic/other) | -14K | sold 17% | 68K | $414K at $29.00 | Aug 6, 26 |
Schneyer Mark C. Officer | Other | 14K | added 21% | 82K | $255K at $17.84 | Aug 6, 26 |
Schneyer Mark C. Officer | Sold (automatic/other) | -6K | sold 7.9% | 68K | $170K at $29.00 | Aug 5, 26 |
Schneyer Mark C. Officer | Other | 6K | added 8.6% | 74K | $104K at $17.84 | Aug 5, 26 |
Thompson Elizabeth H.Z. Officer | Sold (automatic/other) | -17K | sold 47% | 19K | $433K at $26.13 | Jul 30, 26 |
Thompson Elizabeth H.Z. Officer | Other | 32K 0.02% of company | added 100% | 36K | n/a | Jul 29, 26 |
Kihara James Officer | Sold (automatic/other) | -11K | sold 47% | 13K | $298K at $26.08 | Jun 26, 26 |
Poole Jonathan Director | Other | 2K | n/a | 2K | n/a | May 29, 26 |
Brege Laura Director | Other | 8K | added 54% | 23K | n/a | May 29, 26 |
Garofalo Elizabeth A. Director | Other | 8K | added 32% | 33K | n/a | May 29, 26 |
Daly James M Director | Other | 8K | added 100% | 12K | n/a | May 29, 26 |
Ndu Adora Director | Other | 8K | added 33% | 33K | n/a | May 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ACAD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACAD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ACAD last traded at $20.59, down 0.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Acadia Pharmaceuticals Inc. (ACAD) is next expected to report earnings on Wednesday, November 4, 2026 (after close), about 3 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACAD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACAD 81 times in the last 30 days.
ACAD (Acadia Pharmaceuticals Inc.) trades on XNAS, with a market cap of about $3.55B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACAD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACAD discussion
Sign in to ask a question or join the discussion.